[Original Papers published in 2006-2019]

M. Saitoh, K. Takayama, K. Hitachi, A. Taguchi, A. Taniguchi, K. Tsuchida, Y. Hayashi. Discovery of a follistatin-derived myostatin inhibitory peptide.Bioorganic & Medicinal Chemistry Letters.30(3), 126892 (2020)[Pubmed]


K. Hitachi, K. Tsuchida. Regulatory roles of long non-coding RNAs in skeletal muscle differentiation, regeneration, and disorders. The Chemical Biology of Long Noncoding RNAs.RNA Technologies SeriesVol.10 (Eds. Stefan Jurga and Jan Barciszewski) Springer Nature (2020) (in press) 20191029 accepted


K. Hitachi, H. Inagaki, H. Kurahashi, H. Okada, K. Tsuchida, M. Honda. Deficiency of Vgll2 Gene Alters the Gene Expression Profiling of Skeletal Muscle Subjected to Mechanical Overload.Frontiers in Sports and Active Living, Exercise Physiology, Data ReportARTICLE09 October (2019)[Pubmed]


Z. Zhong, S. Liu, W, Zhu, Y. Ou, H. Yamaguchi, K. Hitachi, K. Tsuchida, J. Tian, S. Komatsu,. Phosphoproteomics reveals the biosynthesis of secondary metabolites in Catharanthus roseus under ultraviolet-B radiation.J. Proteomics Res.18(9), 3328-3341 (2019)[Pubmed]


H. Ageta, K. Tsuchida. Invited review. Post-translational modification and protein sorting to small extracellular vesicles including exosomes by ubiquitin and UBLs.CMLS-Cellular and Molecular Life SciencesJul 30. (2019)[Pubmed]

Z. Zhong, S. Liu,W. Zhu,Y. Ou, H. Yamaguchi, K. Hitachi, K. Tsuchida, J. Tian, S. Komatsu. Phosphoproteomics Reveals the Biosynthesis of Secondary Metabolites in Catharanthus roseus under Ultraviolet-B Radiation.J Proteome Res. (2019)[Pubmed]


K. Hitachi, K. Tsuchida. Data describing the effects of depletion of Myoparr, myogenin, Ddx17, and hnRNPK in differentiating C2C12 cells.Data in brief25,104172(2019)[Pubmed]

M. Ikemoto‐Uezumi, A. Uezumi, L. Zhang, H. Zhou, N. Hashimoto, K. Okamura, Y. Matsui, K. Tsukazaki, T. Hosoyama, M. Nakatani, M. Morita, H. Yamada, K. Tsuchida, SI. Fukada. Reduced expression of calcitonin receptor is closely associated with age related loss of the muscle stem cell pool.J. Cachexia, Sarcopenia and Muscle, rapid communication. Clinical Reports2(1), e00081 (2019)[Pubmed]

K. Hitachi, M. Nakatani, K. Tsuchida. Long non-coding RNA Myoparr regulates GDF5 expression in denervated mouse skeletal muscle.Non-coding RNA5(2), 33 (2019)[Pubmed]

M. Aslam, S.u. Rehman, A. Khatoon, M. Jamil,H. Yamaguchi, K. Hitachi, K. Tsuchida, X. Li, Y. Sunohara, H. Matsumoto, S. Komatsu.Molecular responses of maize shoot to plant derived smoke solution.Int J Mol Sci.20: 1319 (2019)[Pubmed]


T. Nagaoka, M. Furuse, T. Ohtsuka, K. Tsuchida, M. Kishi.Vangl2 interaction plays a role in the proteasomal degradation of Prickle2.Sicentific Reports. 9: 2912 (2019)[Pubmed]


HM. Jhanzab, A. Razzaq, Y. Bibi, F. Yasmeen, H. Yamaguchi, K. Hitachi, K. Tsuchida, S. Komatsu.Proteomic Analysis of the Effect of Inorganic and Organic Chemicals on Silver Nanoparticles in Wheat.Int J Mol Sci. 20(4)(2019)[Pubmed]


M. Honda, H. Tsuchimochi, K. Hitachi, S. Ohno.Transcriptional cofactor Vgll2 is required for functional adaptations of skeletal muscle induced by chronic overload.J Cell Physiol.(2019)[Pubmed]


K. Tsuchida. Evaluation of clinical outcomes of pancreatic cancer patients using circulating nucleic acids.Transl Gastroenterol Hepatol.4;2. (2019)[Pubmed]


K. Hitachi, M. Nakatani, A. Takasaki, Y. Ouchi, A. Uezumi, H. Ageta, H. Inagaki, H. Kurahashi, K. Tsuchida. Myogenin promoter-associated lncRNA Myoparr is essential for myogenic differentiation.EMBO Rep.e47468.(2019)[Pubmed]


H. Ageta, N. Ageta-Ishihara, K. Hitachi, O. Karayel, T. Onouchi, H. Yamaguchi, T. Kahyo, K. Hatanaka, K. Ikegami, Y. Yoshioka, K. Nakamura, N. Kosaka, M. Nakatani, A. Uezumi, T. Ide, Y. Tsutsumi, H. Sugimura, M. Kinoshita, T. Ochiya, M. Mann, M. Setou, K. Tsuchida. UBL3 modification influences protein sorting to small extracellular vesicles.Nature communications. 9; 3936. (2018)[Pubmed]


K. Tsuchida, M. Nakatani, K. Hitachi. Therapeutic strategies against muscular dystrophy and related atrophic disorders.Journal of Translational Science. 5(5): 1-3, (2018)[Pubmed]


R. Kurokawa, R. Komiya, T. Oyoshi, Y. Matsuno, H. Tani, M. Katahira, K. Hitachi, Y. Iwashita, T. Yamashita, K. Kondo, R. Yoneda, Y. Yamaoki, N. Ueda, T. Mashima, N. Kobayashi, T. Nagata, A. Kiyoishi, M. Miyake, F. Kano, M. Murata, N. Hamad, K. Sasaki, N. Shoji. Multiplicity in Long Noncoding RNA in Living Cells.Biomedical Sciences. 4(2):18-23; (2018)[Pubmed]


X. Li, SU. Rehman, H. Yamaguchi, K. Hitachi, K. Tsuchida, T. Yamaguchi, Y. Sunohara, H. Matsumoto, S. Komatsu.Proteomic analysis of the effect of plant-derived smoke on soybean during recovery from flooding stress.J. Proteomics.181; 238-248. (2018)[Pubmed]


T. Kasai, M. Nakatani, N. Ishiguro, K. Ohno, N. Yamamoto, M. Morita, H. Yamada, K. Tsuchida, A. Uezumi. Promethazine hydrochloride inhibits ectopic fat cell formation in skeletal musce.

Am. J. Pathol.187(12); 2627-2634. (2017)[Pubmed]


H. Sakai, S. Fukuda, M. Nakamura, A. Uezumi, Y-t. Noguchi, T. Sato, M. Morita, H. Yamada, K. Tsuchida, S. Tajbakhsh, S.-i. Fukada. Notch ligands regulate the muscle stem-like state ex vivo but are not sufficient for retaining regenerative capacity.PLoS One12(5); e0177516 (2017)[Pubmed]


C. Kimura, H. Ageta, H. Yamaguchi, T. Kuroiwa, D. Ikeda, M. Morita, K. Hayakawa, K. Tsuchida, H. Yamada. A comprehensive proteomics analysis of blood sera from patients of osteoarthritis. - Comparative study before and after total joint replacement surgery -J. Orthopedic Research Therapy4 JORT-131 (2017)[Pubmed]


K. Hitachi, K. Tsuchida. Myostatin-deficiency in mice increases global gene expression at the Dlk1-Dio3 locus in the skeletal muscle. Biomedical Advances,Musculoskeletal Disorder9 (2017)[Link]


T. Kuroiwa, H. Ageta, D. Ikeda, M. Morita, K. Tsuchida, H. Yamada. Serum level of PRDX6 is elevated in osteoarthritis patients 3 months after surgery.Clinics in SurgeryVolume 2, 1378 (2017)[Pubmed]


A. Hashiguchi, K. Hitachi, W. Zhu, J. Tian, K. Tsuchida, S. Komatsu. Mung bean (Vigna radiata (L.)) coat extract modulates macrophage functions to enhance antigen presentation: a proteomic study.J. Proteomics161, 26-37 (2017) [Pubmed]


J. Hino, M. Nakatani, Y. Arai, K. Tsuchida, M. Shirai, M. Miyazato, K. Kangawa. Overexpression of bone morphogenetic protein-3b (BMP-3b) in adipose tissues protects against high-fat diet induced obesity with alteration of energy expenditure.Int. J. Obesity. 41(4), 483-488 (2017) [Pubmed]

K. Hitachi, K. Tsuchida. Myostatin-deficiency in mice increases global gene expression at the Dlk1-Dio3 locus in the skeletal muscle.Oncotarget8, 5943-5953 (2017)[Pubmed]


A Uezumi, M. Nakatani, M. Ikemoto-Uezumi, N. Yamamoto, M. Morita, H. Yamada, T. Kasai, Y. Miyagoe-Suzuki, S.-I. Takeda, S. Fukada, I. Nishino, and K. Tsuchida他. Cell surface protein profiling identifies distinctive markers of progenitor cells in human skeletal muscle. Stem Cell Report 7(2) : 263-278 (2016)[Pubmed]

A Uezumi, T. Kasai, K. Tsuchida. Identification, isolation, and characterization of mesenchymal progenitors in mouse and human skeletal muscle. Skeletal Muscle Regeneration, Springer Methods in Molecular Biology series. Methods Mol Biol1460:241-253. (2016)[Pubmed]

K. Tsuchida, K. Hitachi, M. Nakatani, A. Uezumi, H. Ageta. Chapter 1. The role of myostatin and related factors in muscle hypertrophy and atrophy in myostatin: Structure, role in muscle development and health implications. Nova Publishers, 2nd Quarter-2016.[Pubmed]

M. Yamaguchi, Y. Watanabe, A. Uezumi, M. Hoshino, K. Tsuchida, Y. Miyagoe-Suzuki, K. Tsujikawa, S.-I. Takeda, H. Yamamoto, S.I. Fukada 他. Calcitonin receptor signalling inhibits muscle stem cells from escaping the quiescent state and the niche. Cell Reports 13(2), 302-314. (2015)[Pubmed]

K. Tsuchida. Drug delivery systems for cancer treatment. Encyclopedia of Cancer 3rd ed. (Manfred Schwab Ed.) pp1-3 (2015)

Y. Ohsawa, K. Takayama, S. Nishimatsu, K. Tsuchida, Y. Sunada他7人

The inhibitory core of the myostatin prodomain: Its interaction with both type I and II membrane receptors, and potential to treat muscle atrophy.PLoS One10(7), e0133713 (2015)[Pubmed]

M. Ikemoto-Uezumi, A. Uezumi, K. Tsuchida, S. Fukada, H. Yamamoto, N. Yamamoto, K. Shiomi, N. Hashimoto. Pro-IGF-II ameliorates age-related inefficient regenerative response by orchestrating self-reinforcement mechanism of muscle regeneration. Stem Cells33(8), 2456-2468 (2015)[Pubmed]


A. Uezumi, S. Fukada, N. Yamamoto, M. Ikemoto-Uezumi, M. Nakatani, M. Morita, A. Yamaguchi, H. Yamada, I. Nishino, Y. Hamada, K. Tsuchida. Identification and characterization of PDGFRα mesenchymal progenitors in human skeletal muscle.Cell Death Disease(Nature Publishing Group) 5, e1186 (2014)[Pubmed]


K. Tsuchida. Myokines and signal crosstalk between skeletal muscle and adipose tissue. Austin J Endo Metab 1(3), 2 (2014)[Pubmed]


A. Uezumi, M. Ikemoto-Uezumi, K. Tsuchida. Role for nonmyogenic mesenchymal progenitors in pathogenesis and regeneration of skeletal muscle. Frontiers in Physiology:Frontiers in Skeletal Muscle Wasting, Regeneration and Stem Cells. 5, 68, 1-11 (2014)[Pubmed]

K. Hitachi, K. Tsuchida. Role of microRNAs in muscle hypertrophy. Role of microRNAs in muscle hypertrophy. Frontiers in Physiology :MicroRNA and Skeletal Muscle Function: Novel Potential Roles in Exercise, Diseases, and Aging. 4, 408, 1-7 (2014)[Pubmed]

K. Hitachi, M. Nakatani, K. Tsuchida. Myostatin signaling regulates Akt activity via the regulation of miR-486 expression.Int. J. Biochem. Cell Biol.47:93-103(2014)[Pubmed]


D. Ikeda, H. Ageta, K. Tsuchida, H. Yamada. iTRAQ-based proteomics reveals novel biomarkers of osteoarthritis.BioMarkers18(7):565-572 (2013)[Pubmed]

K. Tsuchida, T. Oishi, A. Uezumi, H. Yamada. Origin and therapeutic strategies for ectopic bone formation in skeletal muscle.Human Genet Embryol3:2 (2013)

T. Oishi, A. Uezumi, A. Kanaji, N. Yamamoto, A. Yamaguchi, H. Yamada, K. Tsuchida. Osteogenic differentiation capacity of human skeletal muscle-derived progenitor cells.PLoS One8(2), e56641 (2013)[Pubmed]

T. Murakami, M. Nakatani, M. Kokubo, H. Nakatsuji, M. Inada, H. Imahori, M. Yudasaka, S. Iijima, K. Tsuchida, Mechanism of cell interactions with water-dispersed carbon nanohorns.Nanoscience and Nanotechnology Letters5(3), 402-407 (2013)

T. Murakami, M. Yudasaka, S. Iijima, K. Tsuchida. Characterization of inorganic nanomaterials as therapeutic vehicles.Recent Advances Medicinal Chemistry1, 165-188 (2012)

Y. Ohsawa, T. Okada, S. Nishimatsu, M. Ishizaki, T. Suga, M. Fujino, T. Murakami, M. Uchino, K. Tsuchida, S. Noji, A. Hinohara, T. Shimizu, K. Shimizu, Y. Sunada. An inhibitor of transforming growth factor beta type I receptor ameliorates muscle atrophy in a mouse model of caveolin 3-deficient muscular dystrophy.Lab. Invest.92(8), 1100-1114 (2012)[Pubmed]

M. Nakatani, M. Kokubo, Y. Ohsawa, Y. Sunada, K. Tsuchida. Follistatin-derived peptide expression in muscle decreases adipose tissue mass and prevents hepatic steatosis.Am. J. Physiol. Endocrinol. Metab.300(3), E543-553 (2011)[Pubmed](Editor’s Choice selected)

H. Ageta, K. Tsuchida. Multifunctional roles of activins in the brain.Vitamins and Hormones(G. Litwack Ed.) 85, 185-206 (2011)[Pubmed]

M. Nakamura, Y. Tahara, Y. Ikehara, T. Murakami, K. Tsuchida, S. Iijima, I. Waga, M. Yudasaka. Single-walled carbon nanohorns as drug carriers: adsorption of prednisolone and anti-inflammatory effects on arthritis.Nanotechnology22(46), 465102 (2011)[Pubmed]

A. Uezumi, T. Ito, S. Takeda, K. Tsujikawa, K. Tsuchida, H. Yamamoto, S. Fukada 他11名

Fibrosis and adipogenesis originate from a common mesenchymal progenitor in skeletal muscle.J. CellScience124(Pt21), 3654-3664 (2011)[Pubmed]

M. Ishikawa, N. Nishijima, J. Shiota, H. Sakagami, K. Tsuchida, M. Mizukoshi, M. Fukuchi, M. Tsuda, A. Tabuchi. Involvement of the SRF coactivator megakaryoblastic leukemia in the activin-regulated dendritic complexity of rat cortical neurons.J. Biol. Chem.285(43), 32734-32743 (2010)[Pubmed]

S.-J. Lee, Y.-S. Lee, T.A. Zimmers, A. Soleimani,M.M. Matzuk, K. Tsuchida, R. D. Cohn, E. R. Barton. Regulation of muscle mass by follistatin and activins.Mol. Endocrinol.24(10), 1998-2008 (2010)[Pubmed]

T. Murakami, W. Wijagkanalan, M. Hashida, K. Tsuchida. Intracellular drug delivery by genetically engineered high density lipoprotein nanoparticle.Nanomed. 5(6), 867-879 (2010)[Pubmed]

T. Murakami, K. Tsuchida, M. Hashida, H. Imahori. Size control of lipid-based drug carrier by drug loading.Mol. BioSystems6, 789-791 (2010)[Pubmed](Highlights in Chemical Biology)

H. Ageta, S. Ikegami, M. Miura, M. Masuda, R. Migishima, T. Hino, N. Takashima, A. Murayama, H. Sugino, M. Setou, S. Kida, M. Yokoyama, Y. Hasegawa, K. Tsuchida, T. Aosaki, K. Inokuchi. Activin plays a key role in the maintenance of long-term memory and late-LTP.Learning and Memory17(4), 176-185 (2010)[Pubmed](press released) (Editor’s choice selected)

A. Uezumi, S. Fukada, N. Yamamoto, S.-I. Takeda, K. Tsuchida. Mesenchymal progenitors distinct from muscle satellite cells contribute to ectopic fat cell formation in skeletal muscle.Nature Cell Biology12(2), 143-152 (2010)[Pubmed](News & Views selected)

T. Kitamura, Y. Saitoh, N. Takashima, A. Murayama, Y. Niibori, H. Ageta, M. Sekiguchi, H. Sugiyama, K. Inokuchi. Adult neurogenesis modulates the hippocampus-dependent period of associative fear memory.Cell139(4), 814-827 (2009)[Pubmed]

Y. Oshima, N. Ouchi, M. Shimano, D.R. Pimentel, K.N. Papanicolaou, K.D. Panse, K. Tsuchida, E. Lara-Pezzi, S.-J. Lee, K. Walsh. Activin A and follistatin-like 3 determine the susceptibility of heart to ischemic injury.Circulation120(16), 1606-1615 (2009)[Pubmed]

A. Uezumi, K. Tsuchida. Roles of mesenchymal progenitors, distinct from satellite cells, in Muscle Cell Physiology (edited by Y. Ohira). Osaka University Press pp109-119 (2009)

H. Ageta, S. Asai, Y. Sugiura, N. Goto-Inoue, N. Zaima, M. Setou. Layer-specific sulfatide localization in rat hippocampus middle molecular layer is revealed by nanoparticle-assisted laser desorption/ionization imaging mass spectrometry.Medical Molecular Morphology.42(1),16-23 (2009)[Pubmed]

K. Tsuchida, M. Nakatani, K. Hitachi, A. Uezumi, Y. Sunada, H. Ageta, K. Inokuchi. Activin signaling as an emerging target for therapeutic interventions.Cell Commun. Signal.7(1), 15 (2009)[Pubmed]

J. Miyawaki, S. Matsumura, R. Yuge, T. Murakami, S. Sato, A. Tomida, T. Tsuruo, T. Ichihashi, T. Fujinami, H. Irie, K. Tsuchida, S. Iijima, K. Shiba, M. Yudasaka.Biodistribution and ultrastructural localization of single-walled carbon nanohorns determined in vivo with embedded Gd2O3 labels.ACS nano3(6), 1399-1406 (2009)[Pubmed]

H. Gilson, O. Schakman, S. Kalista, P. Lause, K. Tsuchida, J. Thissen. Follistatin induces muscle hypertrophy through satellite cell proliferation and inhibition of both myostatin and activin.Am. J. Physiol. Endocrinol & Metabol.297, 157-164 (2009)[Pubmed]

A. S. D. Sandanayaka, O. Ito, M. Zhang, K. Ajima, S. Iijima, M. Yudasaka, T. Murakami, K. Tsuchida. Photoinduced electron transfer in Zinc phthalocyanine loaded on single-walled carbon nanohorns in aqueous solution.Advanced Materials21(43), 4366-4371 (2009)[Pubmed]

M. Asashima, Y. Ito, T. Chan, T. Michiue, M. Nakanishi, K. Suzuki, K. Hitachi, K. Okabayashi, A. Kondow, T. Ariizumi. In vitro organogenesis from undifferentiated cells in Xenopus.Developmental Dynamics238(6), 1309-1320 (2009)[Pubmed]

K. Hitachi, A. Kondow, H. Danno, Y. Nishimura, K. Okabayashi, M. Asashima. Molecular analyses of Xenopus laevis Mesp-related genes.Integrative Zoology. 4, 387-394 (2009)[Pubmed]

K. Hitachi, H. Danno, S. Tazumi, Y. Aihara, H. Uchiyama, K. Okabayashi, A. Kondow, M. Asashima. The Xenopus Bowline/Ripply family proteins negatively regulate the transcriptional activities of T-box transcription factors.Int. J. Dev. Biol.53: 631-639 (2009)[Pubmed]

M. Sekiguchi, F. Hayashi, K. Tsuchida, K. Inokuchi. Neuron type-selective effects of activin on development of the hippocampus.Neuroscience Letters452(3), 232-237 (2009)[Pubmed]

K. Jinno, T. Takahashi, K. Tsuchida, E. Tanaka, K. Moriyama. Acceleration of palate wound healing in Smad 3-deficient mice.J. Dental Res.88(8), 757- 761 (2009)[Pubmed]

K. Ajima, T. Murakami, Y. Mizoguchi, K. Tsuchida, T. Ichihashi, S. Iijima, M. Yudasaka. Enhancement of in vivo anticancer effects of cisplatin by incorporation inside single-wall carbon nanohorns.ACS Nano2(10), 2057-2064 (2008)[Pubmed]

K. Tsuchida, M. Nakatani, T. Murakami, A. Uezumi. Action of myostatin and its regulators in skeletal myogenesis. In Recent advances of skeletal muscle differentiation. (Editors : K. Tsuchida, S. Takeda)Research Signpost.pp109-126 (2008)[Pubmed]

K. Tsuchida. Myostatin inhibition by a follistatin-derived peptide ameliorates the pathophysiology of muscular dystrophy model mice.Acta Myologica14-18 (2008)[Pubmed]

Y. Ohsawa, T. Okada, A. Kuga, S. Hayashi, T. Murakami, K. Tsuchida, S. Noji, Y. Sunada. Caveolin-3 regulates myostatin signaling.Acta Myologica19-24 (2008)[Pubmed]

K. Tsuchida. Drug delivery systems for cancer treatment.Encyclopedia of Cancer2nd ed (Manfred Schweb Ed.) pp909-911 (2008)

M. Zhang, T. Murakami, K. Ajima, K. Tsuchida, A.S.D. Sandanayaka, O. Ito, S. Iijima, M. Yudasaka. Fabrication of ZnPc/protein nanohorns for double photodynamic and hyperthermic cancer phototherapy.Proc. Natl. Acad. Sci. U.S.A.105(39), 14773-14778 (2008) (Press release)[Pubmed]

T. Murakami, H. Sawada, G. Tamura, M. Yudasaka, S. Iijima, K. Tsuchida. Water-dispersed single-wall carbon nanohorns as drug carriers for local cancer chemotherapy.Nanomed.3(4), 453-63 (2008)[Pubmed]

K. Tsuchida. Targeting myostatin for therapies against muscle-wasting disorders.Curr. Opin. Drug Discov. Devel.11(4), 487-494 (2008)[Pubmed]

H. Ageta, A. Murayama, R. Migishima, S. Kida, K. Tsuchida, M. Yokoyama, K. Inokuchi. Activin in the brain modulates anxiety-related behavior and adult neurogenesis.PLos ONEe1869 (2008)[Pubmed]

K. Tsuchida, M. Nakatani, A. Uezumi, T. Murakami and X. Cui. Signal transduction pathway through activin receptors as a therapeutic target of musculoskeletal diseases and cancer.Endocrine J.55(1), 11-21 (2008)[Pubmed]

A. Kurisaki, I. Inoue, K. Kurisaki, N. Yamakawa, K. Tsuchida, H. Sugino. Activin induces long-lasting N-methyl-d-aspartate receptor activation via scaffolding PDZ protein activin receptor interacting protein 1.Neuroscience151(4), 1225-1235 (2008)[Pubmed]

T. Murakami and K. Tsuchida. Recent advances in inorganic nanoparticle-based drug delivery systems.Mini. Rev. Med. Chem.8(2), 175-183 (2008)[Pubmed]

M. Nakatani, Y. Takehara, H. Sugino, M. Matsumoto, O. Hashimoto, Y. Hasegawa, T. Murakami, A. Uezumi, S. Takeda, S. Noji, Y. Sunada, and K. Tsuchida. Transgenic expression of a myostatin inhibitor derived from follistatin increases skeletal muscle mass and ameliorates dystrophic pathology in mdx mice.FASEB J.22(2), 477-487 (2008)[Pubmed]

H. Ogino, S. Yano, S. Kakiuchi, H. Muguruma, K. Ikuta, H. Uehara, K. Tsuchida, H. Sugino and S. Sone. Follistatin Suppresses the Production of Experimental Multiple-organ Metastasis by Small Cell Lung Cancer Cells in NK cell-Depleted SCID Mice.Clin. Cancer Res.14(3), 660-667 (2008)[Pubmed]

Y. Shoji-Kasai, H. Ageta, Y. Hasegawa, K. Tsuchida, H. Sugino, K. Inokuchi. Activin, a member of the TGF-β superfamily, increases the number of synaptic contacts and the length of dendritic spine necks by modulating spinal actin dynamics.J. Cell Sci.120(21), 3830-3837 (2007)[Pubmed]

Y. Takehara-Kasamatsu, K. Tsuchida, M. Nakatani, T. Murakami, A. Kurisaki, O. Hashimoto, H. Ohuchi, H. Kurose, K. Mori, S. Kagami, S. Noji, H. Sugino. Characterization of follistatin-related gene as a negative regulatory factor for activin family members during mouse heart development.J. Med. Invest.54(3-4), 276-288 (2007)[Pubmed]

K. Pryor-Koishi, H. Nishizawa, T. Kato, H. Kogo, T. Murakami, K. Tsuchida, H. Kurahashi, Y. Udagawa. Overproduction of the follistatin-related gene protein in the placenta and maternal serum of women with pre-eclampsia.Brit. J. Obst. Gynaecol.114(9), 1128-1137 (2007)[Pubmed]

Y. Morine, K. Tsuchida, H. Sugino, K. Takamura, S. Tashiro, M. Shimada. Effects of preactivation by portal vein ligation on liver regeneration following massive hepatectomy in rats.Hepatogastroenterology54(76), 1216-1221 (2007)[Pubmed]

H. Sawada, H. Ishiguro, K. Nishii, K. Yamada, K. Tsuchida, H. Takahashi, J. Goto, I. Kanazawa, T. Nagatsu. Characterization of neuron-specific huntingtin aggregates in human huntingtin knock-in mice.Neurosci. Res.57(4), 559-573 (2007)[Pubmed]

K. Miyake, K. Tsuchida, H. Sugino, S. Imura, Y. Morine, M. Fujii, M. Shimada. Combination therapy of human pancreatic cancer implanted in nude mice by oral fluoropyrimidine anticancer agent (S-1) with interferon-alpha.Cancer Chemother. Pharmacol.59(1), 113-126 (2007)[Pubmed]

S. Fukada, A. Uezumi, M. Ikemoto, S. Masuda, M. Segawa, N. Tanimura, H. Yamamoto, Y. Miyagoe-Suzuki, S. Takeda. Molecular signature of quiescent satellite cells in adult skeletal muscle.Stem Cells25, 2448-2459 (2007)[Pubmed]

M. Ikemoto, S. Fukada, A. Uezumi, S. Masuda, H. Miyoshi, H. Yamamoto, M.R. Wada, N. Masubuchi, Y. Miyagoe-Suzuki, S. Takeda. Autologous transplantation of SM/C-2.6+ satellite cells transduced with micro-dystrophin CS1 cDNA by lentiviral vector into mdx mice.Mol. Ther.15:2178-2185 (2007)[Pubmed]

Y. Ohsawa, H. Hagiwara, M. Nakatani, A. Yasue, K. Moriyama, T. Murakami, K. Tsuchida, S. Noji, Y. Sunada. Muscular atrophy of caveolin-3-deficient mice is rescued by myostatin inhibition.J. Clin. Invest.116(11), 2924-2934 (2006)[Pubmed]

K. Tsuchida, Y. Sunada, S. Noji, T. Murakami, A. Uezumi, M. Nakatani. Inhibitors of the TGF-beta superfamily and their clinical applications.Mini. Rev. Med. Chem.6(11), 1255-61 (2006)[Pubmed]

M. Kogame, S. Matsuo, M. Nakatani, A. Kurisaki, H. Nishitani, K. Tsuchida, H. Sugino. ALK7 is a novel marker for adipocyte differentiation.J. Med. Invest.53(3-4), 238-245 (2006)[Pubmed]

M. Funaba, K. Nakaya, T. Ikeda, M. Murakami, K. Tsuchida, H. Sugino. Requirement of Smad3 for mast cell growth.Cell. Immunol.240(1), 47-52 (2006)[Pubmed]

Z.H. Liu, K. Tsuchida, T. Matsuzaki, Y.L. Bao, A. Kurisaki, H. Sugino. Characterization of isoforms of activin receptor-interacting protein 2 that augment activin signaling.J. Endocrinol.189(2), 409-421 (2006)[Pubmed]

K.Y. Arai, K. Tsuchida, C.M. Li, G. Watanabe, H. Sugino, K. Taya, T. Nishiyama. Purification of recombinant activin A using the second follistatin domain of follistatin-related gene (FLRG).Protein Expr. Purif.49(1), 78-82 (2006) [Pubmed]

K. Tsuchida. The role of myostatin and bone morphogenetic proteins in muscular disorders.Expert Opin Biol Ther.6(2), 147-54.(2006)[Pubmed]

M. Funaba, K. Nakaya, T. Ikeda, M. Murakami, K. Tsuchida, H. Sugino. Requirement of Smad3 for mast cell growth.Cell Immunol.240(1), 47-52. (2006)[Pubmed]

M. Funaba, T. Ikeda, M. Murakami, K. Ogawa, Y. Nishino, K. Tsuchida, H. Sugino, M. Abe. Involvement of p38 MAP kinase and Smad3 in TGF-beta-mediated mast cell functions.Cell Signal.18(12), 2154-61. (2006)[Pubmed]

M. Funaba, T. Ikeda, M. Murakami, K. Ogawa, Y. Nishino, K. Tsuchida, H. Sugino, M. Abe. Transcriptional regulation of mouse mast cell protease-7 by TGF-beta.Biochim. Biophys. Acta.1759(3-4), 166-70. (2006)[Pubmed]


2008- 2019 Division for Therapies against Intractable Diseases, ALL RIGHT RESERVED.